FindTrial
Sign In

Pegylated Irinotecan

DRUG2 trials

Sponsors

Roswell Park Cancer Institute, Joel Neal

Conditions

Extensive-stage Small Cell Lung Cancer (SCLC)Metastatic Breast Cancer (mBC)Recurrent Non-small Cell Lung Cancer (NSCLC)Recurrent Small Cell Lung Cancer (SCLC)Recurrent Small Cell Lung CarcinomaStage IV Non-small Cell Lung Cancer (NSCLC)Tumors Metastatic to Brain

Phase 2

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer
CompletedNCT01876446
Roswell Park Cancer InstituteRecurrent Small Cell Lung Carcinoma
Start: 2013-08-29End: 2020-02-24Updated: 2020-03-17
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer
CompletedNCT02312622
Joel NealExtensive-stage Small Cell Lung Cancer (SCLC), Metastatic Breast Cancer (mBC), Recurrent Non-small Cell Lung Cancer (NSCLC) +3
Start: 2015-08-31End: 2019-07-31Updated: 2023-12-12